4.7 Article

Synthesis and antitubercular activity of novel 4-substituted imidazolyl-2,6-dimethyl-N3,N5-bisaryl-1,4-dihydropyridine-3,5-dicarboxamides

Journal

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 44, Issue 8, Pages 3253-3258

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2009.03.027

Keywords

Antitubercular activity; 1,4-Dihydropyridine-3,5-dicarbamoxamide derivatives Mycobacterium tuberculosis

Funding

  1. Isfahan Pharmaceutical Sciences Research Center

Ask authors/readers for more resources

A series of 4-substituted imidazolyl-2,6-dimethyl-N-3,N-5-bisaryl-1,4-dihydropyridine-3,5-dicarboxamides were prepared. They were screened as antitubercular agents against Mycobacterium tuberculosis H(37)Rv. Minimum inhibitory concentrations (MICs) were determined using agar proportion method. Compound 3i with 1-benzyl-2-methylthio-1H-imidazole-5-yl substituent at C-4 position and 4'-chloromophenyl group at C-3 and C-5 positions of the 1,4-dihydropyridine ring was the most potent one among the tested compounds. It was as potent as rifampicin against M. tuberculosis H37RV. Compound 31 also was an active antitubercular agent with the same substituent as compound 3i at the C-4 position and 31-pyridyl group at C-3 and C-5 positions of the 1,4-dihydropyridine ring. (C) 2009 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available